EW Q2 2019 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q2 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.1B+15.2% YoY

Gross Profit

$772M71.0% margin

Operating Income

$271M24.9% margin

Net Income

$242M22.3% margin

EPS (Diluted)

$0.38

QoQ Revenue Growth

+9.5%

Cash Flow

Operating Cash Flow

$341M

Free Cash Flow

$269M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$5.6B

Total Liabilities

$2.1B

Stockholders' Equity

$3.5B

Cash & Equivalents

$727M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$944M	+15.2%
Gross Profit	$772M	$710M	+8.6%
Operating Income	$271M	$282M	-4.1%
Net Income	$242M	$283M	-14.3%

Revenue Segments

Transcatheter Heart Valves

$678M62%

Surgical Heart Valve Therapy

$218M20%

Critical Care

$184M17%

Transcatheter Mitral And Tricuspid Therapies

$7M1%

Geographic Segments

UNITED STATES

$625M57%

Europe

$242M22%

JAPAN

$113M10%

Rest of World

$107M10%